Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Line Melgaard
Author
Added:
3 years ago
Dr Damien Collison (Golden Jubilee National Hospital, Glasgow, UK) discusses the results of An Evaluation of a Physiology-guided PCI Optimisation Strategy (Target-FFR) Trial.
The prospective study assessed the feasibility of achieving post-PCI FFR ≥0.90 during standard PCI procedures in consecutive patients.
Questions
1. Your study highlights substantial variation between final FFR reported…
View more
Author(s):
Arjun K Ghosh
,
Deepak L Bhatt
,
Cezar Iliescu
Added:
2 years ago
Cardio-oncology topic editor, Dr Arjun Ghosh (University College London Hospital and Hatter Cardiovascular Institute, UK) is joined by Dr. Deepak L. Bhatt (Brigham and Women's Hospital, Medical School, US) and Dr Cezar Iliescu(The University of Texas MD Anderson Cancer Center, US) to discuss interventional issues in cancer patients with a focus on patients with acute coronary syndromes (ACS)…
View more
Author(s):
Mohamed Abdel-Wahab
Added:
2 years ago
In this short summary interview, Dr Mohamed Abdel-Wahab (Heart Center Leipzig, University of Leipzig, DE) talks about the findings of the CHOICE-CLOSURE trial. The randomized trial investigated the plug-based versus suture-based large-bore vascular closure.
Discussion points:
1. Importance of this study
2. Study design and patient cohort
3. Key findings
4. Impact on practice
5. Next steps
…
View more
Author(s):
Anuj Gupta
,
Issam Moussa
Added:
3 years ago
The treatment of atherosclerotic coronary artery disease (CAD) using percutaneous coronary intervention (PCI) is a well-established procedure that is performed over one million times a year in the US. The Achilles heel of PCI has been the development of neointimal hyperplasia within the stent, resulting in in-stent restenosis (ISR). Sirolimus-eluting stents (SES) provide a platform that in…
View more
Author(s):
Alia Noorani
,
Vinayak Bapat
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal…
View more
Author(s):
Abhijeet Dhoble
Added:
10 months ago
EuroPCR 23 —We are joined by Dr Abhijeet Dhoble (UT Health, US) to discuss the findings of the TVT-registry analysis on transcatheter aortic valve replacement (TAVR) in patients with cardiogenic shock. (NCT01737528)
The analysis aims to evaluate the outcomes of balloon-expandable bioprosthetic transcatheter aortic valve replacement (TAVR) with SAPIEN 3 and SAPIEN 3 Ultra bioprosthesis in…
View more
Author(s):
Mohamed Adnan Alkhouli
Added:
1 year ago
TCT 22 - Dr Mohamed Alkhouli (Mayo Clinic, Jacksonville, FL, US) joins us to outline the findings from the TVT Registry, a benchmarking tool created to monitor the real-world outcomes of transcatheter mitral valve repair. In this prospective observational study, 4000 patients with mitral valve regurgitation were observed after implantation with the mitraclip device to evaluate the safety and…
View more
Author(s):
David Smith
,
Ahmed Hailan
,
Alexander Chase
Added:
3 years ago
Radial vs Femoral Access
In recent years several large registries and randomised controlled trials have demonstrated a mortality benefit for trans-radial over trans-femoral percutaneous coronary intervention (PCI), likely mediated by reduced bleeding complications.1–4 Building on the pioneering Japanese experience, the advent of the hybrid algorithim approach, coupled with innovative new…
View more